Role of octamer transcription factor 4 in proliferation, migration, drug sensitivity, and stemness maintenance of pancreatic cancer cells

doi:10.5306/wjco.v16.i3.100723

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (445)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

HTML

214

Figures (1-6)

Tables (1-3)

Sum=373

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=53

Mar 24, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Oncol. Mar 24, 2025; 16(3): 100723
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.100723

Full Size Figure Download Figure

Figure 3 Cell migration and invasion. A and B: Octamer transcription factor 4 (OCT4) expression changes affect the invasion ability of BxPC3 cells; C and D: OCT4 expression changes affect the migration ability of BxPC3 cells. ^aP < 0.05. OCT4: Octamer transcription factor 4.

Citation: Shi XY, Wang XL, Zhao J, Yang SH, Zhang CH. Role of octamer transcription factor 4 in proliferation, migration, drug sensitivity, and stemness maintenance of pancreatic cancer cells. World J Clin Oncol 2025; 16(3): 100723
URL: https://www.wjgnet.com/2218-4333/full/v16/i3/100723.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i3.100723